HEADER CHAPERONE 13-DEC-10 2Y22 TITLE HUMAN ALPHAB-CRYSTALLIN DOMAIN (RESIDUES 67-157) COMPND MOL_ID: 1; COMPND 2 MOLECULE: ALPHA-CRYSTALLIN B; COMPND 3 CHAIN: A, B, C, D, E, F; COMPND 4 FRAGMENT: ALPHA-CRYSTALLIN DOMAIN (ACD), RESIDUES 67-157; COMPND 5 SYNONYM: ALPHAB-CRYSTALLIN, ALPHA(B)-CRYSTALLIN, HEAT SHOCK PROTEIN COMPND 6 BETA-5, HSPB5, RENAL CARCINOMA ANTIGEN NY-REN-27, ROSENTHAL FIBER COMPND 7 COMPONENT; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES; COMPND 10 OTHER_DETAILS: SELENOMETHIONE CONTAINING PROTEIN SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR: PPROEX HT(B) KEYWDS SMALL HEAT SHOCK PROTEIN, CHAPERONE, STRESS PROTEIN, EYE LENS KEYWDS 2 PROTEIN, CATARACT EXPDTA X-RAY DIFFRACTION AUTHOR C.E.NAYLOR,C.BAGNERIS,A.R.CLARK,N.H.KEEP,C.SLINGSBY REVDAT 3 08-MAY-19 2Y22 1 REMARK LINK REVDAT 2 13-APR-11 2Y22 1 JRNL REVDAT 1 02-MAR-11 2Y22 0 JRNL AUTH A.R.CLARK,C.E.NAYLOR,C.BAGNERIS,N.H.KEEP,C.SLINGSBY JRNL TITL CRYSTAL STRUCTURE OF R120G DISEASE MUTANT OF HUMAN JRNL TITL 2 ALPHAB-CRYSTALLIN DOMAIN DIMER SHOWS CLOSURE OF A GROOVE JRNL REF J.MOL.BIOL. V. 408 118 2011 JRNL REFN ISSN 0022-2836 JRNL PMID 21329698 JRNL DOI 10.1016/J.JMB.2011.02.020 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH C.BAGNERIS,O.A.BATEMAN,C.E.NAYLOR,N.CRONIN,W.C.BOELENS, REMARK 1 AUTH 2 N.H.KEEP,C.SLINGSBY REMARK 1 TITL CRYSTAL STRUCTURES OF ALPHA-CRYSTALLIN DOMAIN DIMERS OF REMARK 1 TITL 2 ALPHAB-CRYSTALLIN AND HSP20. REMARK 1 REF J.MOL.BIOL. V. 392 1242 2009 REMARK 1 REFN ISSN 0022-2836 REMARK 1 PMID 19646995 REMARK 1 DOI 10.1016/J.JMB.2009.07.069 REMARK 2 REMARK 2 RESOLUTION. 3.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.8.0 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 59.89 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 7846 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.216 REMARK 3 R VALUE (WORKING SET) : 0.213 REMARK 3 FREE R VALUE : 0.277 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.600 REMARK 3 FREE R VALUE TEST SET COUNT : 361 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 5 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 3.70 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 4.14 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2174 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2167 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2079 REMARK 3 BIN R VALUE (WORKING SET) : 0.2138 REMARK 3 BIN FREE R VALUE : 0.2799 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.37 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 95 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3342 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 56.13 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 88.84 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 15.52340 REMARK 3 B22 (A**2) : -23.02580 REMARK 3 B33 (A**2) : 7.50230 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.739 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.854 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.795 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 3413 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 4658 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1067 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 60 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 533 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 3413 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 477 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 3437 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.07 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.54 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 16.94 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: IDEAL-DIST CONTACT TERM CONTACT SETUP. REMARK 3 ALL ATOMS HAVE CCP4 ATOM TYPE FROM LIBRARY REMARK 4 REMARK 4 2Y22 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 13-DEC-10. REMARK 100 THE DEPOSITION ID IS D_1290046637. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 25-JUN-08 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 9 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-4 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.978 REMARK 200 MONOCHROMATOR : CRYSTAL REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 7861 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.700 REMARK 200 RESOLUTION RANGE LOW (A) : 67.400 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 12.80 REMARK 200 R MERGE (I) : 0.24000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 8.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.90 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 13.30 REMARK 200 R MERGE FOR SHELL (I) : 0.66000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 4.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 2Y1Y REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 56.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.80 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: SITTING DROPS WITH 20 MG/ML PROTEIN IN REMARK 280 25 MM TRIS, PH 8.5, 200 MM NACL EQUILIBRATED AGAINST 110 MM REMARK 280 BICINE, PH 9.0, 55% MPD, VAPOR DIFFUSION, SITTING DROP REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 33.64000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 39.17000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 33.64000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 39.17000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4, 5, 6 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 5 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 6 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 ENGINEERED RESIDUE IN CHAIN A, LEU 137 TO MET REMARK 400 ENGINEERED RESIDUE IN CHAIN B, LEU 137 TO MET REMARK 400 ENGINEERED RESIDUE IN CHAIN C, LEU 137 TO MET REMARK 400 ENGINEERED RESIDUE IN CHAIN D, LEU 137 TO MET REMARK 400 ENGINEERED RESIDUE IN CHAIN E, LEU 137 TO MET REMARK 400 ENGINEERED RESIDUE IN CHAIN F, LEU 137 TO MET REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 64 REMARK 465 ALA A 65 REMARK 465 VAL A 152 REMARK 465 SER A 153 REMARK 465 GLY A 154 REMARK 465 PRO A 155 REMARK 465 GLU A 156 REMARK 465 ARG A 157 REMARK 465 GLY B 64 REMARK 465 ALA B 65 REMARK 465 MSE B 66 REMARK 465 GLU B 67 REMARK 465 MSE B 68 REMARK 465 ARG B 69 REMARK 465 LEU B 70 REMARK 465 GLU B 71 REMARK 465 LYS B 72 REMARK 465 ASP B 73 REMARK 465 LYS B 150 REMARK 465 GLN B 151 REMARK 465 VAL B 152 REMARK 465 SER B 153 REMARK 465 GLY B 154 REMARK 465 PRO B 155 REMARK 465 GLU B 156 REMARK 465 ARG B 157 REMARK 465 GLY C 64 REMARK 465 ALA C 65 REMARK 465 MSE C 66 REMARK 465 GLU C 67 REMARK 465 MSE C 68 REMARK 465 ARG C 69 REMARK 465 LEU C 70 REMARK 465 GLU C 71 REMARK 465 LYS C 72 REMARK 465 ASP C 73 REMARK 465 ARG C 74 REMARK 465 ARG C 149 REMARK 465 LYS C 150 REMARK 465 GLN C 151 REMARK 465 VAL C 152 REMARK 465 SER C 153 REMARK 465 GLY C 154 REMARK 465 PRO C 155 REMARK 465 GLU C 156 REMARK 465 ARG C 157 REMARK 465 GLY D 64 REMARK 465 ALA D 65 REMARK 465 MSE D 66 REMARK 465 GLU D 67 REMARK 465 MSE D 68 REMARK 465 ARG D 149 REMARK 465 LYS D 150 REMARK 465 GLN D 151 REMARK 465 VAL D 152 REMARK 465 SER D 153 REMARK 465 GLY D 154 REMARK 465 PRO D 155 REMARK 465 GLU D 156 REMARK 465 ARG D 157 REMARK 465 GLY E 64 REMARK 465 ALA E 65 REMARK 465 MSE E 66 REMARK 465 GLU E 67 REMARK 465 MSE E 68 REMARK 465 ARG E 69 REMARK 465 LEU E 70 REMARK 465 GLU E 71 REMARK 465 LYS E 72 REMARK 465 LYS E 150 REMARK 465 GLN E 151 REMARK 465 VAL E 152 REMARK 465 SER E 153 REMARK 465 GLY E 154 REMARK 465 PRO E 155 REMARK 465 GLU E 156 REMARK 465 ARG E 157 REMARK 465 GLY F 64 REMARK 465 ALA F 65 REMARK 465 MSE F 66 REMARK 465 GLU F 67 REMARK 465 MSE F 68 REMARK 465 ARG F 69 REMARK 465 LEU F 70 REMARK 465 GLU F 71 REMARK 465 LYS F 72 REMARK 465 ASP F 73 REMARK 465 ARG F 74 REMARK 465 PHE F 75 REMARK 465 LYS F 150 REMARK 465 GLN F 151 REMARK 465 VAL F 152 REMARK 465 SER F 153 REMARK 465 GLY F 154 REMARK 465 PRO F 155 REMARK 465 GLU F 156 REMARK 465 ARG F 157 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 67 CG CD OE1 OE2 REMARK 470 ARG A 69 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 71 CG CD OE1 OE2 REMARK 470 LYS A 72 CG CD CE NZ REMARK 470 GLU A 87 CD OE1 OE2 REMARK 470 LYS A 90 CG CD CE NZ REMARK 470 LYS A 92 CD CE NZ REMARK 470 LEU A 94 CG CD1 CD2 REMARK 470 LYS A 103 CG CD CE NZ REMARK 470 GLU A 110 CG CD OE1 OE2 REMARK 470 GLU A 117 CG CD OE1 OE2 REMARK 470 LYS A 121 CD CE NZ REMARK 470 ARG A 123 CG CD NE CZ NH1 NH2 REMARK 470 ASP A 127 CG OD1 OD2 REMARK 470 ASP A 129 CG OD1 OD2 REMARK 470 LYS A 150 CG CD CE NZ REMARK 470 GLN A 151 CG CD OE1 NE2 REMARK 470 ARG B 74 CG CD NE CZ NH1 NH2 REMARK 470 PHE B 75 CG CD1 CD2 CE1 CE2 CZ REMARK 470 ASN B 78 CG OD1 ND2 REMARK 470 LYS B 82 CG CD CE NZ REMARK 470 GLU B 87 CD OE1 OE2 REMARK 470 LYS B 90 CG CD CE NZ REMARK 470 LYS B 92 CD CE NZ REMARK 470 ASP B 96 CG OD1 OD2 REMARK 470 GLU B 105 CG CD OE1 OE2 REMARK 470 GLU B 106 CG CD OE1 OE2 REMARK 470 GLN B 108 CG CD OE1 NE2 REMARK 470 GLU B 110 CG CD OE1 OE2 REMARK 470 LYS B 121 CG CD CE NZ REMARK 470 ARG B 123 CG CD NE CZ NH1 NH2 REMARK 470 ARG B 149 CG CD NE CZ NH1 NH2 REMARK 470 PHE C 75 CG CD1 CD2 CE1 CE2 CZ REMARK 470 GLU C 87 CG CD OE1 OE2 REMARK 470 LYS C 90 CG CD CE NZ REMARK 470 LYS C 92 CG CD CE NZ REMARK 470 GLU C 105 CG CD OE1 OE2 REMARK 470 GLU C 110 CG CD OE1 OE2 REMARK 470 ARG C 123 CG CD NE CZ NH1 NH2 REMARK 470 ARG D 69 CG CD NE CZ NH1 NH2 REMARK 470 LEU D 70 CG CD1 CD2 REMARK 470 GLU D 71 CG CD OE1 OE2 REMARK 470 LYS D 72 CG CD CE NZ REMARK 470 ASP D 73 CG OD1 OD2 REMARK 470 ARG D 74 CG CD NE CZ NH1 NH2 REMARK 470 PHE D 75 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LYS D 82 CD CE NZ REMARK 470 GLU D 87 CG CD OE1 OE2 REMARK 470 LYS D 90 CG CD CE NZ REMARK 470 LYS D 92 CG CD CE NZ REMARK 470 LEU D 94 CG CD1 CD2 REMARK 470 GLU D 99 CG CD OE1 OE2 REMARK 470 GLU D 105 CG CD OE1 OE2 REMARK 470 GLU D 106 CG CD OE1 OE2 REMARK 470 GLU D 110 CG CD OE1 OE2 REMARK 470 HIS D 111 CG ND1 CD2 CE1 NE2 REMARK 470 LYS D 121 CG CD CE NZ REMARK 470 ARG D 123 CG CD NE CZ NH1 NH2 REMARK 470 ASP D 129 CG OD1 OD2 REMARK 470 LEU D 131 CG CD1 CD2 REMARK 470 ASN D 146 CG OD1 ND2 REMARK 470 ASP E 73 CG OD1 OD2 REMARK 470 ARG E 74 CG CD NE CZ NH1 NH2 REMARK 470 PHE E 75 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LEU E 79 CG CD1 CD2 REMARK 470 ASP E 80 CG OD1 OD2 REMARK 470 GLU E 87 CG CD OE1 OE2 REMARK 470 LYS E 90 CG CD CE NZ REMARK 470 LYS E 92 CG CD CE NZ REMARK 470 LEU E 94 CG CD1 CD2 REMARK 470 GLU E 105 CG CD OE1 OE2 REMARK 470 ARG E 107 CG CD NE CZ NH1 NH2 REMARK 470 GLN E 108 CG CD OE1 NE2 REMARK 470 HIS E 119 CG ND1 CD2 CE1 NE2 REMARK 470 LYS E 121 CG CD CE NZ REMARK 470 ARG E 123 CG CD NE CZ NH1 NH2 REMARK 470 LEU E 131 CG CD1 CD2 REMARK 470 LEU E 143 CG CD1 CD2 REMARK 470 ASN E 146 CG OD1 ND2 REMARK 470 ARG E 149 CG CD NE CZ NH1 NH2 REMARK 470 ASN F 78 CG OD1 ND2 REMARK 470 LEU F 79 CG CD1 CD2 REMARK 470 ASP F 80 CG OD1 OD2 REMARK 470 VAL F 81 CG1 CG2 REMARK 470 LYS F 82 CG CD CE NZ REMARK 470 GLU F 87 CD OE1 OE2 REMARK 470 LYS F 90 CG CD CE NZ REMARK 470 LYS F 92 CD CE NZ REMARK 470 LEU F 94 CG CD1 CD2 REMARK 470 ASP F 96 CG OD1 OD2 REMARK 470 LYS F 103 CG CD CE NZ REMARK 470 GLU F 105 CG CD OE1 OE2 REMARK 470 GLU F 106 CG CD OE1 OE2 REMARK 470 GLN F 108 CG CD OE1 NE2 REMARK 470 ASP F 109 CG OD1 OD2 REMARK 470 GLU F 110 CG CD OE1 OE2 REMARK 470 LYS F 121 CG CD CE NZ REMARK 470 ARG F 123 CG CD NE CZ NH1 NH2 REMARK 470 ILE F 124 CG1 CG2 CD1 REMARK 470 ASP F 127 CG OD1 OD2 REMARK 470 VAL F 128 CG1 CG2 REMARK 470 ILE F 133 CG1 CG2 CD1 REMARK 470 MSE F 137 CG SE CE REMARK 470 ARG F 149 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 67 145.29 -19.45 REMARK 500 GLU C 106 109.40 -23.78 REMARK 500 ASP D 73 39.94 -156.15 REMARK 500 ARG D 74 79.42 -151.61 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2WJ7 RELATED DB: PDB REMARK 900 HUMAN ALPHAB CRYSTALLIN REMARK 900 RELATED ID: 2Y1Z RELATED DB: PDB REMARK 900 HUMAN ALPHAB CRYSTALLIN ACD R120G REMARK 900 RELATED ID: 2Y1Y RELATED DB: PDB REMARK 900 HUMAN ALPHAB CRYSTALLIN ACD(RESIDUES 71-157) REMARK 999 REMARK 999 SEQUENCE REMARK 999 L 137 MUTATED TO METHIONINE TO AID IN PHASING ALPHAB REMARK 999 CRYSTALLIN DOMAIN RESIDUES 67-157 DBREF 2Y22 A 67 157 UNP P02511 CRYAB_HUMAN 67 157 DBREF 2Y22 B 67 157 UNP P02511 CRYAB_HUMAN 67 157 DBREF 2Y22 C 67 157 UNP P02511 CRYAB_HUMAN 67 157 DBREF 2Y22 D 67 157 UNP P02511 CRYAB_HUMAN 67 157 DBREF 2Y22 E 67 157 UNP P02511 CRYAB_HUMAN 67 157 DBREF 2Y22 F 67 157 UNP P02511 CRYAB_HUMAN 67 157 SEQADV 2Y22 GLY A 64 UNP P02511 EXPRESSION TAG SEQADV 2Y22 ALA A 65 UNP P02511 EXPRESSION TAG SEQADV 2Y22 MSE A 66 UNP P02511 EXPRESSION TAG SEQADV 2Y22 MSE A 137 UNP P02511 LEU 137 ENGINEERED MUTATION SEQADV 2Y22 GLY B 64 UNP P02511 EXPRESSION TAG SEQADV 2Y22 ALA B 65 UNP P02511 EXPRESSION TAG SEQADV 2Y22 MSE B 66 UNP P02511 EXPRESSION TAG SEQADV 2Y22 MSE B 137 UNP P02511 LEU 137 ENGINEERED MUTATION SEQADV 2Y22 GLY C 64 UNP P02511 EXPRESSION TAG SEQADV 2Y22 ALA C 65 UNP P02511 EXPRESSION TAG SEQADV 2Y22 MSE C 66 UNP P02511 EXPRESSION TAG SEQADV 2Y22 MSE C 137 UNP P02511 LEU 137 ENGINEERED MUTATION SEQADV 2Y22 GLY D 64 UNP P02511 EXPRESSION TAG SEQADV 2Y22 ALA D 65 UNP P02511 EXPRESSION TAG SEQADV 2Y22 MSE D 66 UNP P02511 EXPRESSION TAG SEQADV 2Y22 MSE D 137 UNP P02511 LEU 137 ENGINEERED MUTATION SEQADV 2Y22 GLY E 64 UNP P02511 EXPRESSION TAG SEQADV 2Y22 ALA E 65 UNP P02511 EXPRESSION TAG SEQADV 2Y22 MSE E 66 UNP P02511 EXPRESSION TAG SEQADV 2Y22 MSE E 137 UNP P02511 LEU 137 ENGINEERED MUTATION SEQADV 2Y22 GLY F 64 UNP P02511 EXPRESSION TAG SEQADV 2Y22 ALA F 65 UNP P02511 EXPRESSION TAG SEQADV 2Y22 MSE F 66 UNP P02511 EXPRESSION TAG SEQADV 2Y22 MSE F 137 UNP P02511 LEU 137 ENGINEERED MUTATION SEQRES 1 A 94 GLY ALA MSE GLU MSE ARG LEU GLU LYS ASP ARG PHE SER SEQRES 2 A 94 VAL ASN LEU ASP VAL LYS HIS PHE SER PRO GLU GLU LEU SEQRES 3 A 94 LYS VAL LYS VAL LEU GLY ASP VAL ILE GLU VAL HIS GLY SEQRES 4 A 94 LYS HIS GLU GLU ARG GLN ASP GLU HIS GLY PHE ILE SER SEQRES 5 A 94 ARG GLU PHE HIS ARG LYS TYR ARG ILE PRO ALA ASP VAL SEQRES 6 A 94 ASP PRO LEU THR ILE THR SER SER MSE SER SER ASP GLY SEQRES 7 A 94 VAL LEU THR VAL ASN GLY PRO ARG LYS GLN VAL SER GLY SEQRES 8 A 94 PRO GLU ARG SEQRES 1 B 94 GLY ALA MSE GLU MSE ARG LEU GLU LYS ASP ARG PHE SER SEQRES 2 B 94 VAL ASN LEU ASP VAL LYS HIS PHE SER PRO GLU GLU LEU SEQRES 3 B 94 LYS VAL LYS VAL LEU GLY ASP VAL ILE GLU VAL HIS GLY SEQRES 4 B 94 LYS HIS GLU GLU ARG GLN ASP GLU HIS GLY PHE ILE SER SEQRES 5 B 94 ARG GLU PHE HIS ARG LYS TYR ARG ILE PRO ALA ASP VAL SEQRES 6 B 94 ASP PRO LEU THR ILE THR SER SER MSE SER SER ASP GLY SEQRES 7 B 94 VAL LEU THR VAL ASN GLY PRO ARG LYS GLN VAL SER GLY SEQRES 8 B 94 PRO GLU ARG SEQRES 1 C 94 GLY ALA MSE GLU MSE ARG LEU GLU LYS ASP ARG PHE SER SEQRES 2 C 94 VAL ASN LEU ASP VAL LYS HIS PHE SER PRO GLU GLU LEU SEQRES 3 C 94 LYS VAL LYS VAL LEU GLY ASP VAL ILE GLU VAL HIS GLY SEQRES 4 C 94 LYS HIS GLU GLU ARG GLN ASP GLU HIS GLY PHE ILE SER SEQRES 5 C 94 ARG GLU PHE HIS ARG LYS TYR ARG ILE PRO ALA ASP VAL SEQRES 6 C 94 ASP PRO LEU THR ILE THR SER SER MSE SER SER ASP GLY SEQRES 7 C 94 VAL LEU THR VAL ASN GLY PRO ARG LYS GLN VAL SER GLY SEQRES 8 C 94 PRO GLU ARG SEQRES 1 D 94 GLY ALA MSE GLU MSE ARG LEU GLU LYS ASP ARG PHE SER SEQRES 2 D 94 VAL ASN LEU ASP VAL LYS HIS PHE SER PRO GLU GLU LEU SEQRES 3 D 94 LYS VAL LYS VAL LEU GLY ASP VAL ILE GLU VAL HIS GLY SEQRES 4 D 94 LYS HIS GLU GLU ARG GLN ASP GLU HIS GLY PHE ILE SER SEQRES 5 D 94 ARG GLU PHE HIS ARG LYS TYR ARG ILE PRO ALA ASP VAL SEQRES 6 D 94 ASP PRO LEU THR ILE THR SER SER MSE SER SER ASP GLY SEQRES 7 D 94 VAL LEU THR VAL ASN GLY PRO ARG LYS GLN VAL SER GLY SEQRES 8 D 94 PRO GLU ARG SEQRES 1 E 94 GLY ALA MSE GLU MSE ARG LEU GLU LYS ASP ARG PHE SER SEQRES 2 E 94 VAL ASN LEU ASP VAL LYS HIS PHE SER PRO GLU GLU LEU SEQRES 3 E 94 LYS VAL LYS VAL LEU GLY ASP VAL ILE GLU VAL HIS GLY SEQRES 4 E 94 LYS HIS GLU GLU ARG GLN ASP GLU HIS GLY PHE ILE SER SEQRES 5 E 94 ARG GLU PHE HIS ARG LYS TYR ARG ILE PRO ALA ASP VAL SEQRES 6 E 94 ASP PRO LEU THR ILE THR SER SER MSE SER SER ASP GLY SEQRES 7 E 94 VAL LEU THR VAL ASN GLY PRO ARG LYS GLN VAL SER GLY SEQRES 8 E 94 PRO GLU ARG SEQRES 1 F 94 GLY ALA MSE GLU MSE ARG LEU GLU LYS ASP ARG PHE SER SEQRES 2 F 94 VAL ASN LEU ASP VAL LYS HIS PHE SER PRO GLU GLU LEU SEQRES 3 F 94 LYS VAL LYS VAL LEU GLY ASP VAL ILE GLU VAL HIS GLY SEQRES 4 F 94 LYS HIS GLU GLU ARG GLN ASP GLU HIS GLY PHE ILE SER SEQRES 5 F 94 ARG GLU PHE HIS ARG LYS TYR ARG ILE PRO ALA ASP VAL SEQRES 6 F 94 ASP PRO LEU THR ILE THR SER SER MSE SER SER ASP GLY SEQRES 7 F 94 VAL LEU THR VAL ASN GLY PRO ARG LYS GLN VAL SER GLY SEQRES 8 F 94 PRO GLU ARG MODRES 2Y22 MSE A 66 MET SELENOMETHIONINE MODRES 2Y22 MSE A 68 MET SELENOMETHIONINE MODRES 2Y22 MSE A 137 MET SELENOMETHIONINE MODRES 2Y22 MSE B 137 MET SELENOMETHIONINE MODRES 2Y22 MSE C 137 MET SELENOMETHIONINE MODRES 2Y22 MSE D 137 MET SELENOMETHIONINE MODRES 2Y22 MSE E 137 MET SELENOMETHIONINE MODRES 2Y22 MSE F 137 MET SELENOMETHIONINE HET MSE A 66 8 HET MSE A 68 8 HET MSE A 137 8 HET MSE B 137 8 HET MSE C 137 8 HET MSE D 137 8 HET MSE E 137 8 HET MSE F 137 5 HETNAM MSE SELENOMETHIONINE FORMUL 1 MSE 8(C5 H11 N O2 SE) HELIX 1 1 SER A 85 GLU A 87 5 3 HELIX 2 2 ASP A 129 ILE A 133 5 5 HELIX 3 3 ASP B 129 ILE B 133 5 5 HELIX 4 4 SER C 85 GLU C 87 5 3 HELIX 5 5 ASP C 129 ILE C 133 5 5 HELIX 6 6 ASP D 129 ILE D 133 5 5 HELIX 7 7 ASP E 129 ILE E 133 5 5 HELIX 8 8 ASP F 129 ILE F 133 5 5 SHEET 1 AA 4 MSE A 68 LEU A 70 0 SHEET 2 AA 4 ARG A 74 ASP A 80 -1 O SER A 76 N ARG A 69 SHEET 3 AA 4 VAL A 142 PRO A 148 -1 O LEU A 143 N LEU A 79 SHEET 4 AA 4 THR A 134 MSE A 137 -1 O THR A 134 N ASN A 146 SHEET 1 AB 5 LEU A 89 LEU A 94 0 SHEET 2 AB 5 VAL A 97 GLN A 108 -1 O VAL A 97 N LEU A 94 SHEET 3 AB 5 PHE A 113 ARG A 123 -1 O ILE A 114 N ARG A 107 SHEET 4 AB 5 PHE B 113 ARG B 123 -1 O PHE B 113 N LYS A 121 SHEET 5 AB 5 ARG B 107 GLN B 108 -1 O ARG B 107 N ILE B 114 SHEET 1 AC 6 LEU A 89 LEU A 94 0 SHEET 2 AC 6 VAL A 97 GLN A 108 -1 O VAL A 97 N LEU A 94 SHEET 3 AC 6 PHE A 113 ARG A 123 -1 O ILE A 114 N ARG A 107 SHEET 4 AC 6 PHE B 113 ARG B 123 -1 O PHE B 113 N LYS A 121 SHEET 5 AC 6 VAL B 97 LYS B 103 -1 O ILE B 98 N TYR B 122 SHEET 6 AC 6 LEU B 89 LEU B 94 -1 O LYS B 90 N HIS B 101 SHEET 1 BA 2 ARG B 107 GLN B 108 0 SHEET 2 BA 2 PHE B 113 ARG B 123 -1 O ILE B 114 N ARG B 107 SHEET 1 BB 3 PHE B 75 ASP B 80 0 SHEET 2 BB 3 VAL B 142 GLY B 147 -1 O LEU B 143 N LEU B 79 SHEET 3 BB 3 THR B 134 MSE B 137 -1 O THR B 134 N ASN B 146 SHEET 1 CA 3 SER C 76 ASP C 80 0 SHEET 2 CA 3 VAL C 142 ASN C 146 -1 O LEU C 143 N LEU C 79 SHEET 3 CA 3 THR C 134 MSE C 137 -1 O THR C 134 N ASN C 146 SHEET 1 CB 5 LEU C 89 LEU C 94 0 SHEET 2 CB 5 VAL C 97 LYS C 103 -1 O VAL C 97 N LEU C 94 SHEET 3 CB 5 PHE C 113 ARG C 123 -1 O PHE C 118 N GLY C 102 SHEET 4 CB 5 PHE D 113 ARG D 123 -1 O PHE D 113 N LYS C 121 SHEET 5 CB 5 ARG D 107 GLN D 108 1 O ARG D 107 N ILE D 114 SHEET 1 CC 4 LEU C 89 LEU C 94 0 SHEET 2 CC 4 VAL C 97 LYS C 103 -1 O VAL C 97 N LEU C 94 SHEET 3 CC 4 PHE C 113 ARG C 123 -1 O PHE C 118 N GLY C 102 SHEET 4 CC 4 ARG C 107 GLN C 108 1 O ARG C 107 N ILE C 114 SHEET 1 DA 4 LEU D 89 LEU D 94 0 SHEET 2 DA 4 VAL D 97 LYS D 103 -1 O VAL D 97 N LEU D 94 SHEET 3 DA 4 PHE D 113 ARG D 123 -1 O PHE D 118 N GLY D 102 SHEET 4 DA 4 ARG D 107 GLN D 108 1 O ARG D 107 N ILE D 114 SHEET 1 CD 6 LEU C 89 LEU C 94 0 SHEET 2 CD 6 VAL C 97 LYS C 103 -1 O VAL C 97 N LEU C 94 SHEET 3 CD 6 PHE C 113 ARG C 123 -1 O PHE C 118 N GLY C 102 SHEET 4 CD 6 PHE D 113 ARG D 123 -1 O PHE D 113 N LYS C 121 SHEET 5 CD 6 VAL D 97 LYS D 103 -1 O ILE D 98 N TYR D 122 SHEET 6 CD 6 LEU D 89 LEU D 94 -1 O LYS D 90 N HIS D 101 SHEET 1 DB 5 LEU D 89 LEU D 94 0 SHEET 2 DB 5 VAL D 97 LYS D 103 -1 O VAL D 97 N LEU D 94 SHEET 3 DB 5 PHE D 113 ARG D 123 -1 O PHE D 118 N GLY D 102 SHEET 4 DB 5 PHE C 113 ARG C 123 -1 O PHE C 113 N LYS D 121 SHEET 5 DB 5 ARG C 107 GLN C 108 1 O ARG C 107 N ILE C 114 SHEET 1 DC 2 ARG D 107 GLN D 108 0 SHEET 2 DC 2 PHE D 113 ARG D 123 1 O ILE D 114 N ARG D 107 SHEET 1 DD 6 LEU D 89 LEU D 94 0 SHEET 2 DD 6 VAL D 97 LYS D 103 -1 O VAL D 97 N LEU D 94 SHEET 3 DD 6 PHE D 113 ARG D 123 -1 O PHE D 118 N GLY D 102 SHEET 4 DD 6 PHE C 113 ARG C 123 -1 O PHE C 113 N LYS D 121 SHEET 5 DD 6 VAL C 97 LYS C 103 -1 O ILE C 98 N TYR C 122 SHEET 6 DD 6 LEU C 89 LEU C 94 -1 O LYS C 90 N HIS C 101 SHEET 1 DE 3 PHE D 75 ASP D 80 0 SHEET 2 DE 3 VAL D 142 GLY D 147 -1 O LEU D 143 N LEU D 79 SHEET 3 DE 3 THR D 134 MSE D 137 -1 O THR D 134 N ASN D 146 SHEET 1 EA 3 ARG E 74 ASP E 80 0 SHEET 2 EA 3 VAL E 142 PRO E 148 -1 O LEU E 143 N LEU E 79 SHEET 3 EA 3 THR E 134 MSE E 137 -1 O THR E 134 N ASN E 146 SHEET 1 EB 5 LEU E 89 LEU E 94 0 SHEET 2 EB 5 VAL E 97 LYS E 103 -1 O VAL E 97 N LEU E 94 SHEET 3 EB 5 PHE E 113 ARG E 123 -1 O PHE E 118 N GLY E 102 SHEET 4 EB 5 PHE F 113 ARG F 123 -1 O PHE F 113 N LYS E 121 SHEET 5 EB 5 ARG F 107 GLN F 108 1 O ARG F 107 N ILE F 114 SHEET 1 EC 4 LEU E 89 LEU E 94 0 SHEET 2 EC 4 VAL E 97 LYS E 103 -1 O VAL E 97 N LEU E 94 SHEET 3 EC 4 PHE E 113 ARG E 123 -1 O PHE E 118 N GLY E 102 SHEET 4 EC 4 ARG E 107 GLN E 108 1 O ARG E 107 N ILE E 114 SHEET 1 FA 4 LEU F 89 LEU F 94 0 SHEET 2 FA 4 VAL F 97 LYS F 103 -1 O VAL F 97 N LEU F 94 SHEET 3 FA 4 PHE F 113 ARG F 123 -1 O PHE F 118 N GLY F 102 SHEET 4 FA 4 ARG F 107 GLN F 108 1 O ARG F 107 N ILE F 114 SHEET 1 ED 6 LEU E 89 LEU E 94 0 SHEET 2 ED 6 VAL E 97 LYS E 103 -1 O VAL E 97 N LEU E 94 SHEET 3 ED 6 PHE E 113 ARG E 123 -1 O PHE E 118 N GLY E 102 SHEET 4 ED 6 PHE F 113 ARG F 123 -1 O PHE F 113 N LYS E 121 SHEET 5 ED 6 VAL F 97 LYS F 103 -1 O ILE F 98 N TYR F 122 SHEET 6 ED 6 LEU F 89 LEU F 94 -1 O LYS F 90 N HIS F 101 SHEET 1 FB 5 LEU F 89 LEU F 94 0 SHEET 2 FB 5 VAL F 97 LYS F 103 -1 O VAL F 97 N LEU F 94 SHEET 3 FB 5 PHE F 113 ARG F 123 -1 O PHE F 118 N GLY F 102 SHEET 4 FB 5 PHE E 113 ARG E 123 -1 O PHE E 113 N LYS F 121 SHEET 5 FB 5 ARG E 107 GLN E 108 1 O ARG E 107 N ILE E 114 SHEET 1 FC 2 ARG F 107 GLN F 108 0 SHEET 2 FC 2 PHE F 113 ARG F 123 1 O ILE F 114 N ARG F 107 SHEET 1 FD 6 LEU F 89 LEU F 94 0 SHEET 2 FD 6 VAL F 97 LYS F 103 -1 O VAL F 97 N LEU F 94 SHEET 3 FD 6 PHE F 113 ARG F 123 -1 O PHE F 118 N GLY F 102 SHEET 4 FD 6 PHE E 113 ARG E 123 -1 O PHE E 113 N LYS F 121 SHEET 5 FD 6 VAL E 97 LYS E 103 -1 O ILE E 98 N TYR E 122 SHEET 6 FD 6 LEU E 89 LEU E 94 -1 O LYS E 90 N HIS E 101 SHEET 1 FE 3 VAL F 77 ASP F 80 0 SHEET 2 FE 3 VAL F 142 ASN F 146 -1 O LEU F 143 N LEU F 79 SHEET 3 FE 3 THR F 134 MSE F 137 -1 O THR F 134 N ASN F 146 LINK C MSE A 66 N GLU A 67 1555 1555 1.37 LINK C GLU A 67 N MSE A 68 1555 1555 1.36 LINK C MSE A 68 N ARG A 69 1555 1555 1.35 LINK C SER A 136 N MSE A 137 1555 1555 1.34 LINK C MSE A 137 N SER A 138 1555 1555 1.34 LINK C SER B 136 N MSE B 137 1555 1555 1.34 LINK C MSE B 137 N SER B 138 1555 1555 1.35 LINK C SER C 136 N MSE C 137 1555 1555 1.34 LINK C MSE C 137 N SER C 138 1555 1555 1.36 LINK C SER D 136 N MSE D 137 1555 1555 1.35 LINK C MSE D 137 N SER D 138 1555 1555 1.35 LINK C SER E 136 N MSE E 137 1555 1555 1.34 LINK C MSE E 137 N SER E 138 1555 1555 1.35 LINK C SER F 136 N MSE F 137 1555 1555 1.35 LINK C MSE F 137 N SER F 138 1555 1555 1.35 CRYST1 67.280 78.340 131.400 90.00 90.00 90.00 P 21 21 2 24 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014863 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012765 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007610 0.00000 MTRIX1 1 -0.440140 -0.520590 0.731610 -40.65305 1 MTRIX2 1 -0.479700 -0.552430 -0.681690 -13.10399 1 MTRIX3 1 0.759050 -0.651000 -0.006580 21.90426 1 MTRIX1 2 -0.647050 -0.696620 -0.309910 -30.51887 1 MTRIX2 2 -0.166750 -0.267330 0.949070 -68.17198 1 MTRIX3 2 -0.743990 0.665770 0.056810 21.05918 1 MTRIX1 3 0.489230 0.872130 -0.006100 0.09719 1 MTRIX2 3 0.871960 -0.488960 0.024690 -39.36850 1 MTRIX3 3 0.018550 -0.017400 -0.999680 43.45347 1 MTRIX1 4 -0.560980 0.825690 -0.059530 -18.37072 1 MTRIX2 4 -0.827620 -0.561010 0.017820 -28.72197 1 MTRIX3 4 -0.018680 0.059270 0.998070 44.49226 1 MTRIX1 5 -0.060130 0.010770 -0.998130 -5.84620 1 MTRIX2 5 0.672300 0.739570 -0.032520 10.07737 1 MTRIX3 5 0.737840 -0.673000 -0.051710 66.42694 1